Beginning in December 2019, an outbreak of "pneumonia of unknown cause" was detected in Wuhan City, Hubei Province, China. Ultimately, the 2019 novel coronavirus, or SARS-CoV-2, was identified as the causative agent and subsequently isolated and sequenced.^[@CIT0001]^ Since that time, SARS-CoV-2 has spread worldwide, causing a severe illness known as COVID-19 (coronavirus disease 2019), which led the World Health Organization (WHO) to declare it a pandemic on March 11, 2020.^[@CIT0002]^ Since the beginning of the outbreak, clinical laboratories have been developing various assays to aid in detecting SARS-CoV-2 and clinically managing patients with COVID-19.

The 3 categories of tests used to detect current or past viral infection are molecular, serologic, and antigen-detection assays ([Table 1](#T1){ref-type="table"}). In this context, a molecular assay is used to determine whether a patient is actively infected with the pathogen of interest. Reverse transcription polymerase chain reaction (RT-PCR) is a common laboratory technique used to detect respiratory viral pathogens, such as influenza and respiratory syncytial virus (RSV).^[@CIT0003]^ Currently, this is the main type of test being utilized to determine whether patients are infected with SARS-CoV-2.

###### 

Clinical Laboratory Testing Types

  Test Type                                                           Patient Specimen Type                     Detection                             Clinical Utility               Necessary Reagents             Development Time
  ------------------------------------------------------------------- ----------------------------------------- ------------------------------------- ------------------------------ ------------------------------ ----------------------------------------------------------------------------------------------------------------------------------
  Nucleic acid amplification (ie, RT-PCR, isothermal amplification)   NP swab^a^                                RNA                                   Active infection               Oligo primers                  *Fastest:* oligonucleotide production and molecular assay development (takes days to weeks)
  Serology                                                            Serum                                     IgM and/or IgG, or total antibodies   Past exposure; immune status   Recombinant/purified protein   *Intermediate:* production of viral protein (recombinant/purified) and assay development/optimization (takes 2 to several weeks)
  Protein detection                                                   NP swab and/or other clinical fluids^a^   Viral antigen                         Active infection               Antibody to viral protein(s)   *Slowest:* requires antibody production, assay development, and optimization (takes several weeks to months)

**Abbreviations:** RT-PCR, reverse transcription polymerase chain reaction; NP, nasopharyngeal; Ig, immunoglobulin.

^a^NP swabs are difficult to access using this method.

RT-PCR is a sensitive technique for RNA detection, whereby RNA is reverse transcribed into complementary DNA (cDNA) and cDNA targets specific for the pathogen of interest are amplified. If SARS-CoV-2 RNA is present in a patient specimen, typically collected as a nasopharyngeal (NP) or anterior nasal swab,^[@CIT0004]^ it will be detected by this assay. Depending on the platform, these assays can be completed in less than 1 hour to several hours, once the specimen arrives in the laboratory and is loaded onto the platform.

The caveats to interpreting results from this assay type are that doing so does not inform us whether a patient previously had the infection; rather, this type of assay only detects patients actively shedding virus (current infection or carriage state) or those who have residual viral RNA present. Therefore, these assays are most useful in acute settings to detect patients with COVID-19, where the results can inform appropriate isolation protocols and ensure that appropriate personal protective equipment (PPE) protocols are utilized when treating these patients. As of the date of publication of this article, of the 102 commercial laboratories and/or test kit manufacturers approved for emergency use by the United States Food and Drug Administration (FDA) for SARS-CoV-2 testing, 81 of them were molecular assays ([Table 2](#T2){ref-type="table"}). We note that many of these commercial assays require a laboratory to have vendor-specific instrumentation and equipment to utilize these test kits. The FDA also has authorized 37 molecular-based laboratory developed tests (LDTs) that can be used in the single laboratory that developed the test.

###### 

Current FDA Emergency Use Authorized SARS-CoV-2 Assays, as of May 26, 2020

  Molecular                                                                                                                                                                                
  --------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------
  1drop Inc.                                                                              1copy COVID-19 qPCR Multi Kit                                                                    RT-PCR
  Abbott Diagnostics Scarborough, Inc.                                                    ID NOW COVID-19                                                                                  Isothermal nucleic acid amplification
  Abbott Molecular                                                                        Abbott RealTime SARS-CoV-2 assay                                                                 RT-PCR
  Abbott Molecular Inc.                                                                   Alinity m SARS-CoV-2 assay                                                                       RT-PCR
  Altona Diagnostics GmbH                                                                 RealStar SARS-CoV02 RT-PCR Kits U.S.                                                             RT-PCR
  Applied BioCode, Inc.                                                                   BioCode SARS-CoV-2 Assay                                                                         RT-PCR
  Applied DNA Sciences, Inc.                                                              Linea COVID-19 Assay Kit                                                                         RT-PCR
  Assurance Scientific Laboratories                                                       Assurance SARS-CoV-2 Panel                                                                       RT-PCR
  Atila BioSystems, Inc.                                                                  iAMP COVID-19 Detection Kit                                                                      Isothermal amplification test
  Avellino Lab USA, Inc.                                                                  AvellinoCoV2 test                                                                                RT-PCR
  Becton, Dickinson & Company                                                             BD SARS-CoV-2Reagents for BD MAX System                                                          RT-PCR
  Becton, Dickinson & Company (BD)                                                        BioGX SARS-CoV-2 Reagents for BD MAX System                                                      RT-PCR
  BGI Genomics Co. Ltd                                                                    Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV                                    RT-PCR
  BioCore Co., Ltd.                                                                       BioCore 2019-nCoV Real Time PCR Kit                                                              RT-PCR
  Bio-Rad Laboratories, Inc                                                               Bio-Rad SARS-CoV-2 ddPCR Test                                                                    RT-PCR
  BioFire Defense, LLC                                                                    BioFire COVID-19 Test                                                                            RT-PCR
  BioFire Defense, LLC                                                                    BioFire Respiratory Panel 2.1 (RP2.1) \*panel includes 20 other viral or bacterial pathogens     RT-PCR
  BioMérieux SA                                                                           SARS-COV-2 R-GENE                                                                                RT-PCR
  Centers for Disease Control and Prevention's (CDC)                                      CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC)                                            RT-PCR
  Cepheid                                                                                 Xpert Xpress SARS-CoV-2 test                                                                     RT-PCR
  ChromaCode Inc.                                                                         HDPCR SARS-CoV-2 Assay                                                                           RT-PCR
  Co-Diagnostics, Inc.                                                                    Logix Smart Coronavirus Disease 2019 (COVID-19) Kit                                              RT-PCR
  Cue Health Inc.                                                                         Cue COVID-19 Test                                                                                Isothermal nucleic acid amplification
  dba SpectronRx                                                                          Hymon SARS-CoV-2 Test Kit                                                                        RT-PCR
  DiaCarta, Inc                                                                           QuantiVirus SARS-CoV-2 Test kit                                                                  RT-PCR
  DiaSorin Molecular LLC                                                                  Simplexa COVID-19 Direct assay                                                                   RT-PCR
  Everlywell, Inc.                                                                        Everlywell COVID-19 Test Home Collection Kit                                                     RT-PCR
  Euroimmun US Inc.                                                                       EURORealTime SARS-CoV-2                                                                          RT-PCR
  Fast Track Diagnostics Luxembourg S.á.r.l.                                              FTD SARS-CoV-2                                                                                   RT-PCR
  Fosun Pharma USA Inc.                                                                   Fosun COVID-19 RT-PCR Detection Kit                                                              RT-PCR
  Fulgent Therapeutics, LLC                                                               Fulgent COVID-19 by RT-PCR Test                                                                  RT-PCR
  GeneMatrix, Inc.                                                                        NeoPlex COVID-19 Detection Kit                                                                   RT-PCR
  Genetron Health (Beijing) Co., Ltd.                                                     Genetron SARS-CoV-2 RNA Test                                                                     RT-PCR
  GenMark Diagnostics, Inc.                                                               ePlex SARS-CoV-2 Test                                                                            PCR, electrochemical detection (voltammetry)
  GenoSensor, LLC                                                                         GS™ COVID-19 RT-PCR KIT                                                                          RT-PCR
  Gnomegen LLC                                                                            Gnomegen COVID-19 RT-Digital PCR Detection Kit                                                   RT-PCR
  Gnomegen LLC                                                                            Gnomegen COVID-19-RT-qPCR Detection Kit                                                          RT-PCR
  Gravity Diagnostics, LLC                                                                Gravity Diagnostics COVID-19 Assay                                                               RT-PCR
  Hologic, Inc.                                                                           Aptima SARS-CoV-2 assay                                                                          Target capture, transcription mediated amplification and dual kinetic assay
  Hologic, Inc.                                                                           Panther Fusion SARS-CoV-2                                                                        RT-PCR
  Illumina, Inc.                                                                          Illumina COVIDSeq Test                                                                           Next-Generation Sequencing (NGS)
  InBios International, Inc                                                               Smart Detect SARS-CoV-2 rRT-PCR Kit                                                              RT-PCR
  Ipsum Diagnostics, LLC                                                                  COV-19 IDx assay                                                                                 RT-PCR
  Kaiser Permanente Mid-Atlantic States                                                   KPMAS COVID-19 Test                                                                              RT-PCR
  KorvaLabs Inc.                                                                          Curative-Korva SARS-Cov-2 Assay                                                                  RT-PCR
  LabGenomics Co., Ltd.                                                                   LabGun COVID-19 RT-PCR Kit                                                                       RT-PCR
  Laboratory Corporation of America (LabCorp)                                             COVID-19 RT-PCR Test                                                                             RT-PCR
  Luminex Corporation                                                                     ARIES SARS-CoV-2 Assay                                                                           RT-PCR
  Luminex Molecular Diagnostics, Inc.                                                     NxTAG CoV Extended Panel Assay                                                                   RT-PCR
  Maccura Biotechnology (USA) LLC                                                         SARS-CoV-2 Fluorescent PCR Kit                                                                   RT-PCR
  Mesa Biotech Inc.                                                                       Accula SARS-Cov-2 Test                                                                           PCR and lateral flow assay
  NeuMoDx Molecular, Inc.                                                                 NeuMoDx SARS-CoV-2 Assay                                                                         RT-PCR
  OPTI Medical Systems, Inc.                                                              OPTI SARS-CoV-2 RT PCR Test                                                                      RT-PCR
  OSANG Healthcare                                                                        GeneFinder COVID-19 Plus RealAmp Kit                                                             RT-PCR
  P23 Labs, LLC.                                                                          P23 Labs TaqPath SARS-CoV-2 Assay                                                                RT-PCR
  PerkinElmer, Inc.                                                                       PerkinElmer New Coronavirus Nucleic Acid Detection Kit                                           RT-PCR
  Phosphorus Diagnostics LLC                                                              Phosphorus COVID-19 RT-qPCR Test                                                                 RT-PCR
  Primerdesign Ltd.                                                                       Primerdesign Ltd COVID-19 genesig Real-Time PCR assay                                            RT-PCR
  PrivaPath Diagnostics, Inc.                                                             LetsGetChecked Coronavirus (COVID-19) Test                                                       RT-PCR
  QIAGEN GmbH                                                                             QIAstat-Dx Respiratory SARS-CoV-2 Panel \*panel includes 22 other viral or bacterial pathogens   RT-PCR
  Quest Diagnostics Infectious Disease, Inc.                                              Quest SARS-CoV-2 rRT-PCR                                                                         RT-PCR
  Quidel Corporation                                                                      Lyra SARS-CoV-2 Assay                                                                            RT-PCR
  Quidel Corporation                                                                      Lyra Direct SARS-CoV-2 Assay                                                                     RT-PCR
  Rheonix, Inc.                                                                           Rheonix COVID-19 MDx Assay                                                                       RT-PCR
  Roche Molecular Systems, Inc. (RMS)                                                     cobas SARS-CoV-2                                                                                 RT-PCR
  RTA Laboratories Biological Products Pharmaceutical and Machinery Industry              Diagnovital SARS-CoV-2 Real-Time PCR Kit                                                         RT-PCR
  Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University   Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2-Assay                                    RT-PCR
  Sansure BioTech Inc.                                                                    Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing)             RT-PCR
  ScienCell Research Laboratories                                                         ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit                        RT-PCR
  SD Biosensor, Inc.                                                                      STANDARD M nCoV Real-Time Detection Kit                                                          RT-PCR
  Seasun Biomaterials                                                                     U-TOP COVID-19 Detection Kit                                                                     RT-PCR
  Seasun Biomaterials, Inc.                                                               AQ-TOP COVID-19 Rapid Detection Kit                                                              RT-LAMP
  Seegene, Inc.                                                                           Allplex 2019-nCoV Assay                                                                          RT-PCR
  Sherlock BioSciences, Inc.                                                              Sherlock CRISPR SARS-CoV-2 Kit                                                                   CRISPR
  SolGent Co., Ltd.                                                                       DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit                                             RT-PCR
  TBG Biotechnology Corp.                                                                 ExProbe SARS-CoV-2 Testing Kit                                                                   RT-PCR
  Thermo Fisher Scientific, Inc.                                                          TaqPath COVID-19 Combo Kit                                                                       RT-PCR
  Tide Laboratories, LLC                                                                  DTPM COVID-19 RT-PCR Test                                                                        RT-PCR
  Trax Management Services Inc.                                                           PhoenixDx 2019-CoV                                                                               RT-PCR
  Wadsworth Center, New York State Department of Public Health's (CDC)                    New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel                    RT-PCR
  Zymo Research Corporation                                                               Quick SARS-CoV-2rRT-PCR Kit                                                                      RT-PCR
  Serology                                                                                                                                                                                 
  **Manufacturer**                                                                        **Test Name**                                                                                    **Assay Type**
  Abbott Laboratories Inc.                                                                SARS-CoV-2 IgG assay                                                                             Chemiluminescent microparticle immunoassay
  Autobio Diagnostics Co. Ltd.                                                            Anti-SARS-CoV-2 Rapid Test IgM and IgG                                                           Lateral flow immunoassay
  Bio-Rad Laboratories, Inc                                                               Platelia SARS-CoV-2 Total Ab assay                                                               Enzyme-Linked Immunosorbent Assays (ELISA)
  Cellex Inc.                                                                             qSARS-CoV-2 IgG/IgM Rapid Test                                                                   Lateral flow immunoassay
  Chembio Diagnostic System, Inc.                                                         DPP COVID-19 IgM/IgG System                                                                      Immunochromatography
  DiaSorin Inc.                                                                           LIAISON SARS-CoV-2 S1/S2 IgG                                                                     Chemiluminescent immunoassay
  Emory Medical Laboratories                                                              SARS-CoV-2 RBD IgG test                                                                          Enzyme-Linked Immunosorbent Assays (ELISA)
  EUROIMMUN US Inc.                                                                       Anti-SARS-CoV-2 ELISA (IgG)                                                                      Enzyme-Linked Immunosorbent Assays (ELISA)
  Hangzhou Biotest Biotech Co., Ltd.                                                      RightSign COVID-19 IgG/IgM Rapid Test Cassette                                                   Lateral flow chromatographic immunoassay
  Healgen Scientific LLC                                                                  COVID-19 IgG/IgM Rapid Test Cassette                                                             Lateral flow immunoassay
  InBios International, Inc.                                                              SCoV-2 Detect IgG ELISA                                                                          ELISA
  Mount Sinai Laboratory                                                                  COVID-19 ELISA IgG Antibody Test                                                                 Enzyme-Linked Immunosorbent Assays (ELISA)
  Ortho Clinical Diagnostics, Inc.                                                        VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack                              Immunometric luminescence
  Ortho-Clinical Diagnostics, Inc.                                                        VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack                                Immunometric luminescence
  Roche Diagnostics                                                                       Elecsys Anti-SARS-CoV-2                                                                          Electrochemiluminescence Immunoassay
  Siemens Healthcare Diagnostics Inc.                                                     Dimension Vista SARS-CoV-2 Total antibody assay (COV2T)                                          Chemiluminescent immunoassay
                                                                                          Dimension EXL SARS-CoV-2 Total antibody assay (CV2T)                                             Chemiluminescent immunoassay
                                                                                          Atellica IM SARS-CoV-2 Total (COV2T)                                                             Chemiluminescent immunoassay
                                                                                          ADVIA Centaur SARS-CoV-2 Total (COV2T)                                                           Chemiluminescent immunoassay
  Vibrant America Clinical Labs                                                           Vibrant COVID-19 Ab Assay                                                                        Chemiluminescence immunoassay
  Wadsworth Center, New York State Department of Health                                   New York SARS-CoV Microsphere Immunoassay for Antibody Detection                                 Microsphere Immunoassay
  Antigen                                                                                                                                                                                  
  **Manufacturer**                                                                        **Test Name**                                                                                    **Assay Type**
  Quidel Corporation                                                                      Sofia 2 SARS Antigen FIA                                                                         Lateral flow immunofluorescent sandwich assay

**Abbreviations:** FDA, United States Food and Drug Administration; qPCR, quantitative polymerase chain reaction; RT-PCR, reverse transcriptase polymerase chain reaction; ddPCR, droplet digital polymerase chain reaction; CDC, Centers for Disease Control and Prevention; PCR, polymerase chain reaction; Ig, immunoglobulin; ELISA, enzyme-linked immunosorbent assay; FIA, fluorescence immunoassay analyzer.

^a^As of May 26, 2020. For the most up-to-date list, please refer to: <https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations>. We also note that based on the FDA policy for Diagnostic Tests for Coronavirus Disease--2019 during the Public Health Emergency issued on March 16, 2020, commercial manufacturers can develop and distribute serology tests without an emergency-use authorization (EUA), as long as the test has been validated and the FDA is notified.

^b^Panel includes 20 other viral or bacterial pathogens.

Given that true NP specimens are often difficult to obtain, the FDA has stated that oropharyngeal (OP), nasal midturbinate, and anterior nares swabs are acceptable when using an NP swab is not possible.^[@CIT0004]^ Also, the FDA recently granted an Emergency-Use Authorization (EUA) to Rutgers Clinical Genomics Laboratory-Rutgers University for an RT-PCR LDT for qualitative detection of SARS-CoV-2 in saliva specimens as well as OP, NP, anterior nasal, and midturbinate nasal swabs. Saliva testing presents potential benefits of eliminating the need for swabs and decreasing the risk posed to the health-care workers collecting these specimens. However, this specimen type might require additional dilution or pretreatment due to its viscosity. Also, viral RNA might be more difficult to detect in this specimen type, although the results of a previous study^[@CIT0005]^ found that saliva and NP specimens were comparable for detection of respiratory viruses by RT-PCR.

The possibility of false negative results with molecular assays should also be considered. One report^[@CIT0006]^ documents a patient with multiple RT-PCR NP/OP specimens that tested negative; this patient ultimately had SARS-CoV-2 detected in a bronchoalveolar lavage (BAL) fluid specimen. For lower respiratory tract specimens, currently, the FDA recommends testing BAL fluid only under certain clinical circumstances such as invasive mechanical ventilation. Sputum should be tested from patients who develop a productive cough, although the FDA does not recommend induction of sputum for SARS-CoV-2 testing.^[@CIT0004]^

The other main type of assay is serological. These assays determine the exposure history and/or immune status of a patient. They detect the presence of antibodies against SARS-CoV-2 antigens in serum, plasma, or whole blood specimens. After initial viral infection, there is a delay before the production of antibodies by the immune system ([Figure 1](#F1){ref-type="fig"}). During this time, known as the *window period*, a patient who is infected with SARS-CoV-2 but has no detectable antibodies, would have negative test results on a serologic assay. Typically, when the immune system mounts a response against a virus, short-lived immunoglobulin (Ig)M antibodies are initially produced, followed by a more durable IgG antibody response. However, there are limited data thus far in the literature regarding the longevity of anti--SARS-CoV-2 antibodies.
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The graph in [Figure 1](#F1){ref-type="fig"} demonstrates estimated viral RNA, IgM, and IgG detection levels for SARS-CoV-2 based on the limited published literature to date. The estimated median seroconversion time is 7 to 12 days; most patients with COVID-19 have detectable antibodies approximately 15 days after the onset of symptoms. Due to the subjectivity in determining symptom onset, these dates can be highly variable. Also, viral RNA has been shown to peak in the first week of illness and then gradually decline.

Serological tests can be unique to one class of immunoglobulins; can detect IgM and IgG antibodies simultaneously; or can be total antibody tests, which detect IgA antibodies as well. Depending on the exact protocol and platform, such assays can typically be completed in 1 to 2 hours once a specimen arrives in the laboratory and is loaded onto the relevant platform. We note, however, that at the time of publication of this article, there are a few commercial assays available on large, automated analyzers, from diagnostic manufacturers including Roche Diagnostics, Abbott Diagnostics, and Ortho Clinical Diagnostics (with offerings more recently available from Beckman Coulter, Inc and Siemens AG). However, to our knowledge, there are no objective, peer-reviewed data on their performance characteristics.

Many available commercial serological assays use a lateral flow assay format; for many of these assays, there are unsubstantiated, or even false, claims about test performance.^[@CIT0007]^The estimated median seroconversion time is 7 to 12 days, with virtually all patients with COVID-19 having detectable antibodies approximately 15 days after onset of symptoms.^[@CIT0008]^ However, the results of a recent acute antibody response study^[@CIT0011]^ demonstrated simultaneous or sequential IgM and IgG seroconversion, with a slight decrease in IgM antibody titers 3 weeks after symptom onset. Therefore, these assays will be most helpful in determining the exposure status of an individual and in assessing the immune response of that person to SARS-CoV-2.

Because SARS-CoV-2 is a new virus, it is not clear whether an immune response confers immunity and how long the immune response will last---that is, whether it is durable and sustained (years) or if it is short-lived (1--2 months). These assays can be particularly helpful for individuals who may have had symptoms consistent with COVID-19 but who were never tested with an RT-PCR test (due to the severe limitations in testing capabilities in many areas) and now have recovered from their illness. Currently, the Centers for Disease Control and Prevention (CDC) does not recommend using serology testing to determine eligibility to return to the in-person workforce. Individuals who were symptomatic can stop self-isolation as long as their symptoms have improved with 3 days of no fever and at least 10 days have elapsed since the onset of their symptoms.^[@CIT0012]^

Finally, these tests can also be used in serosurveillance, in which data are obtained to calculate the prevalence of anti--SARS-CoV-2 antibodies in the community. Such information can help epidemiologists better understand the true burden of disease and to model continued viral-transmission dynamics based on the percentage of the population that is immune vs susceptible. Given that approximately 80% of COVID-19 cases are mild to moderate in severity^[@CIT0010],[@CIT0013]^ and that molecular testing has been restricted to the most severely ill patients, the true number of cases has likely not been revealed by molecular-based assays. Thus, serological testing can provide a more accurate enumeration of the number of past infections. As with all laboratory testing, however, the results of these assays will only be accurate and maximally useful based on their performance characteristics, including sensitivity and specificity.

COVID-19 testing is also important for identifying potential patients who have recovered from COVID-19 and have detectable antibodies against SARS-CoV-2 (*convalescent donors*) for clinical trials. Currently, studies are underway in which convalescent donors can donate plasma, which can then be transfused into critically ill patients with COVID-19. A review of the published literature to date^[@CIT0014]^ indicates that treatment with plasma from convalescent donors demonstrates beneficial effects, although further evaluation with clinical trials remains imperative. Potential donors require a serologic assay to detect the presence of anti--SARS-CoV-2 antibodies in their plasma. For this type of plasma to be beneficial, the antibodies present should have neutralizing activity (ie, the antibodies bind to and neutralize infection by active SARS-CoV-2 virus). Such testing is not currently performed in clinical laboratories but rather in research laboratories. Ideally, convalescent plasma donors would be noninfectious (symptom-free for \>14 days) and have high titers of virus-neutralizing antibodies (as determined by serologic testing).

Point-of-care (POC) testing is beginning to be available for SARS-CoV-2. POC testing refers to a broad category of diagnostic tests that can be performed where patient care occurs. Functionally, these tests have a rapid turnaround time (TAT) and can potentially be performed by various nonlaboratory clinical personnel. These assays can be molecular or serologic. One molecular POC test by Abbott Diagnostics uses isothermal nucleic acid amplification (a technique similar to polymerase chain reaction \[PCR\]) to detect SARS-CoV-2 in approximately 15 minutes. The results of recent studies^[@CIT0015]^ have demonstrated low sensitivity for the Abbott ID Now assay with specimens collected in transport media. Thus, the EUA for this test was modified for testing only from direct/dry swabs.

The Cellex serologic POC qSARS-CoV-2 IgG/IgM Rapid Test (Cellex, Inc.) utilizes a lateral flow immunoassay, which qualitatively detects IgM and/or IgG antibodies from whole-blood specimens. A blood specimen flows by capillary action along the cassette and, if anti--SARS-CoV-2 IgM or IgG antibodies are present, they will bind to recombinant SARS-CoV-2 antigens present on the test strip. The presence of these antibody-antigen complexes are then detected by a colorimetric change, which is revealed when the complexes are captured by anti--human IgG or anti--human IgM antibodies. The results are available in approximately 15 to 20 minutes. Of note, currently POC serology tests must be performed in conjunction with a CLIA (Clinical Laboratory Improvement Amendments)--licensed laboratory and cannot be performed in locations with only a CLIA waiver, such as a physician office.

Finally, there is now an antigen detection assay available from Quidel Corporation (Sofia 2 SARS Antigen FIA) that uses a lateral flow immunofluorescent sandwich assay technique for detection of the nucleocapsid protein antigen of SARS-CoV and SARS-CoV-2. In theory, viral proteins can be detected using one of a number of antigen capture methods (eg, antibodies, aptamers). Such tests are used routinely for other viral assays (eg, human immunodeficiency virus \[HIV\] p24 antigen as part of 4^th^- and 5^th^-generation HIV tests), and also for hepatitis B surface antigen.^[@CIT0018]^ Like molecular assays, antigen detection tests can be used to detect active SARS-CoV-2 infection.

In summary, molecular and serological tests provide meaningful data for treating patients with COVID-19. However, each category has different clinical utility, different characteristics, and different limitations. Clinical laboratories continue to develop new assays and implement increased testing capabilities to meet the high demands for patient testing during this pandemic.
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